Dr. Robert Den featured in ASCO Post

29
Oct

For men with prostate cancer who have had a prostatectomy and salvage radiation therapy, analyzing their tumor genome provides clues as to whether their cancer will metastasize, thereby enabling clinicians to better personalize treatment options, according to research presented by Robert Den, MD.  ASTRO 2015: Genomic Classifier Appears to Predict Metastasis in Patients With Prostate Cancer Following Prostatectomy

See Full article here:  http://www.ascopost.com/ViewNews.aspx?nid=33980&utm_medium=Email&utm_source=ExactTarget&utm_campaign=&utm_term=4703395